US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

35.69

+1.343.90%

Post-market: 35.690.00000.00%19:49 EDT

Volume:2.69M

Turnover:95.67M

Market Cap:4.21B

PE:12.90

High:35.90

Open:34.76

Low:34.47

Close:34.35

52wk High:42.81

52wk Low:22.22

Shares:118.00M

Float Shares:116.45M

Volume Ratio:1.27

T/O Rate:2.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.77

EPS(LYR):1.64

ROE:12.20%

ROA:26.40%

PB:-20.25

PE(LYR):21.76

Loading ...

Overview Company News Filings

Indivior CFO Ryan Preblick sells 36,000 shares for $1.36 million

Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV)

Will Real-World SUBLOCADE Adherence Data Reshape Indivior Pharmaceuticals' (INDV) Long-Acting OUD Treatment Narrative

Simply Wall St.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

Indivior study links monthly injectable buprenorphine adherence to lower opioid relapse risk

Indivior’s Earnings Call Highlights SUBLOCADE-Driven Surge

Lifeward names Keith D. Rose chief medical officer

Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership

Indivior eliminates chief scientific officer role; Heidbreder departs end-2026

Indivior Pharmaceuticals Inc - to Eliminate Chief Scientific Officer Position Effective June 1, 2026 - SEC Filing

THOMSON REUTERS

Indivior Pharmaceuticals, Inc : Stifel Raises Target Price to $52 From $42

THOMSON REUTERS

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News

Simply Wall St.

Sector Update: Health Care

MT Newswires Live

Indivior Pharmaceuticals Enters $175 Million Accelerated Share Repurchase Agreement

MT Newswires Live

Indivior announces $175M accelerated share repurchase program

Indivior Announces $175 Million Accelerated Share Repurchase

THOMSON REUTERS

Indivior Earnings Call Highlights SUBLOCADE-Fueled Momentum

Indivior Pharmaceuticals, Inc reports results for the quarter ended March 31 - Earnings Summary

Indivior Pharmaceuticals Q1 revenue rises 19%, beats estimates

Indivior Pharmaceuticals Q1 Revenue USD 317 Million Vs. IBES Estimate USD 272.8 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/INDV/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"INDV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","market":"US","secType":"STK","nameCN":"INDIVIOR PLC","latestPrice":35.69,"timestamp":1789675200000,"preClose":34.35,"halted":0,"volume":2690472,"hourTrading":{"tag":"盘后","latestPrice":35.69,"preClose":35.69,"latestTime":"19:49 EDT","volume":1052918,"amount":37578649.285,"timestamp":1789688970204,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03901018922852973,"floatShares":116454522,"shares":118000000,"eps":2.766067,"marketStatus":"Not Yet Opened","change":1.34,"latestTime":"09-17 16:00:00 EDT","open":34.76,"high":35.9,"low":34.47,"amount":95671268.70393601,"amplitude":0.04163,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.766067,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":34.35,"preHourTrading":{"tag":"盘前","latestPrice":34.74,"preClose":34.35,"latestTime":"09:29 EDT","volume":9631,"amount":339982.58266,"timestamp":1789651799999,"change":0.39,"changeRate":0.011354,"amplitude":0.067307},"postHourTrading":{"tag":"盘后","latestPrice":35.69,"preClose":35.69,"latestTime":"19:49 EDT","volume":1052918,"amount":37578649.285,"timestamp":1789688970204,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.267572,"impliedVol":0.2953,"impliedVolPercentile":0.0558},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","floatShares":116454522,"roa":"26.40%","roe":"12.20%","lyrEps":1.64,"volumeRatio":1.267572,"shares":118000000,"dividePrice":0,"high":35.9,"amplitude":0.04163,"preClose":34.35,"low":34.47,"week52Low":22.22,"pbRate":"-20.25","psRate":"3.16","week52High":42.81,"institutionHeld":0,"latestPrice":35.69,"eps":2.766067,"divideRate":0,"volume":2690472,"delay":0,"ttmEps":2.766067,"open":34.76,"prevYearClose":35.88,"prevWeekClose":34.49,"prevMonthClose":34.93,"prevQuarterClose":41.03,"fiveDayClose":34.51,"twentyDayClose":39.04,"sixtyDayClose":39.96,"dividendPayoutRate":1.9539525374644688,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.02676056338028169},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INDV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"INDV","fiscalQuarterEnding":"2026/06","expectedEps":0.97,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":1.15},{"market":"US","date":"2026-04-30","symbol":"INDV","fiscalQuarterEnding":"2026/03","expectedEps":0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":0.96},{"market":"US","date":"2026-02-26","symbol":"INDV","fiscalQuarterEnding":"2025/12","expectedEps":0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.82},{"market":"US","date":"2026-01-26","symbol":"INDV","reason":null,"defaultRemindTime":1769437800000,"announcedDate":"2026-01-23","type":"delisting","dateTimestamp":1769403600000},{"market":"US","date":"2025-10-30","symbol":"INDV","fiscalQuarterEnding":"2025/09","expectedEps":0.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INDV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INDV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1781841600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INDV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INDV","date":"2026-09-16","current":12.902797,"percent":0.41896,"low":-539.080629,"twenty":-24.967722,"median":17.954474,"eighty":56.235876,"high":1520.868351,"avg":86.844861,"sd":411.769381,"marketCap":4038427068},"quantilePoints":[{"date":"2024-01-05","current":-8.731325,"twenty":-8.731325,"median":-8.731325,"eighty":-8.731325,"marketCap":2051861355.61},{"date":"2024-01-12","current":-9.061129,"twenty":-8.930914,"median":-8.915467,"eighty":-8.872434,"marketCap":2129365213.58},{"date":"2024-01-19","current":-9.036937,"twenty":-9.037083,"median":-8.926675,"eighty":-8.867596,"marketCap":2123680078.16},{"date":"2024-01-26","current":-10.054308,"twenty":-9.927259,"median":-9.036937,"eighty":-8.901284,"marketCap":2362762158.39},{"date":"2024-02-02","current":-10.004449,"twenty":-10.01442,"median":-9.223686,"eighty":-8.919649,"marketCap":2351045521.54},{"date":"2024-02-09","current":-10.098427,"twenty":-10.051065,"median":-9.895497,"eighty":-8.929219,"marketCap":2373130321.56},{"date":"2024-02-16","current":-10.175342,"twenty":-10.179852,"median":-9.943541,"eighty":-8.977536,"marketCap":2391205561.35},{"date":"2024-02-23","current":1442.16344,"twenty":-10.183288,"median":-9.929623,"eighty":-8.965881,"marketCap":2884326878.5},{"date":"2024-03-01","current":1520.868351,"twenty":-10.175772,"median":-9.860171,"eighty":-8.862758,"marketCap":3041736702.67},{"date":"2024-03-08","current":1456.331845,"twenty":-10.129193,"median":-9.478841,"eighty":1456.594636,"marketCap":2912663689.17},{"date":"2024-03-15","current":1406.519641,"twenty":-10.071956,"median":-9.037667,"eighty":1456.594636,"marketCap":2813039280.38},{"date":"2024-03-22","current":1416.408463,"twenty":-10.051876,"median":-8.960053,"eighty":1447.830802,"marketCap":2832816924.48},{"date":"2024-03-28","current":1455.260447,"twenty":-10.040734,"median":-8.915467,"eighty":1455.903286,"marketCap":2910520894.48},{"date":"2024-04-05","current":1458.075233,"twenty":-10.017652,"median":-8.848243,"eighty":1457.639065,"marketCap":2916150468.02},{"date":"2024-04-12","current":1329.065563,"twenty":-9.996443,"median":1356.65224,"eighty":1456.726031,"marketCap":2658131124.79},{"date":"2024-04-19","current":1279.103138,"twenty":-9.969287,"median":1309.349865,"eighty":1455.903286,"marketCap":2558206276.88},{"date":"2024-04-26","current":476.533403,"twenty":-9.944147,"median":1284.511395,"eighty":1452.111517,"marketCap":2382667015.68},{"date":"2024-05-03","current":485.430033,"twenty":-9.931801,"median":1275.015426,"eighty":1446.43078,"marketCap":2427150166.81},{"date":"2024-05-10","current":484.77744,"twenty":-9.909437,"median":493.219646,"eighty":1443.862237,"marketCap":2423887197.01},{"date":"2024-05-17","current":457.733314,"twenty":-9.881367,"median":488.116405,"eighty":1441.351048,"marketCap":2288666574.17},{"date":"2024-05-24","current":465.20437,"twenty":-9.858941,"median":485.295631,"eighty":1439.871356,"marketCap":2326021847.95},{"date":"2024-05-31","current":496.261466,"twenty":-9.799964,"median":486.27573,"eighty":1436.258175,"marketCap":2481307333.36},{"date":"2024-06-07","current":439.995107,"twenty":-9.5344,"median":485.430033,"eighty":1423.367779,"marketCap":2199975534.13},{"date":"2024-06-14","current":451.615042,"twenty":-9.386243,"median":484.77744,"eighty":1423.350602,"marketCap":2258075214.65},{"date":"2024-06-21","current":447.135681,"twenty":-9.126152,"median":483.175553,"eighty":1421.904534,"marketCap":2235678403.11},{"date":"2024-06-28","current":420.240739,"twenty":-9.056437,"median":482.881297,"eighty":1420.903799,"marketCap":2101203699.91},{"date":"2024-07-05","current":399.169394,"twenty":-9.037667,"median":478.317711,"eighty":1418.346927,"marketCap":1995846972.62},{"date":"2024-07-12","current":281.71779,"twenty":-9.036937,"median":474.886858,"eighty":1416.476807,"marketCap":1408588947.59},{"date":"2024-07-15","current":269.124484,"twenty":-9.027388,"median":474.396895,"eighty":1416.463138,"marketCap":1345622420.31},{"date":"2024-08-02","current":-12.681184,"twenty":-9.037375,"median":474.162636,"eighty":1416.449469,"marketCap":1788046959.52},{"date":"2024-08-09","current":-11.831658,"twenty":-9.742833,"median":463.001654,"eighty":1415.475285,"marketCap":1668263747.87},{"date":"2024-08-16","current":-11.531835,"twenty":-9.931801,"median":456.721797,"eighty":1411.053167,"marketCap":1625988694.51},{"date":"2024-08-23","current":-11.359567,"twenty":-10.017652,"median":455.124507,"eighty":1403.016644,"marketCap":1601698904.31},{"date":"2024-08-30","current":-11.517339,"twenty":-10.144576,"median":449.847335,"eighty":1394.819348,"marketCap":1623944812.52},{"date":"2024-09-06","current":-9.739044,"twenty":-10.190159,"median":447.535315,"eighty":1390.076063,"marketCap":1373205236.08},{"date":"2024-09-13","current":-9.093341,"twenty":-10.176202,"median":437.901092,"eighty":1388.200752,"marketCap":1282161095.35},{"date":"2024-09-20","current":-8.695405,"twenty":-10.159959,"median":436.792984,"eighty":1385.619667,"marketCap":1226052087.81},{"date":"2024-09-27","current":-9.187795,"twenty":-10.089603,"median":420.240739,"eighty":1373.204246,"marketCap":1295479177.06},{"date":"2024-10-04","current":-9.452398,"twenty":-10.053497,"median":411.279432,"eighty":1328.888735,"marketCap":1332788098.86},{"date":"2024-10-11","current":-6.894174,"twenty":-10.045494,"median":397.767615,"eighty":1324.41511,"marketCap":972078462.1},{"date":"2024-10-18","current":-7.729502,"twenty":-10.022053,"median":275.421137,"eighty":1306.911197,"marketCap":1089859827.76},{"date":"2024-10-25","current":-387.254131,"twenty":-10.022053,"median":258.931158,"eighty":1295.294828,"marketCap":1161762392.56},{"date":"2024-10-31","current":-376.128091,"twenty":-10.098427,"median":-6.913465,"eighty":1287.84805,"marketCap":1128384273.39},{"date":"2024-11-08","current":-434.650258,"twenty":-10.197534,"median":-7.218189,"eighty":1281.174739,"marketCap":1303950773.11},{"date":"2024-11-15","current":-417.553766,"twenty":-10.357169,"median":-7.68996,"eighty":1279.103138,"marketCap":1252661295.74},{"date":"2024-11-22","current":-455.401138,"twenty":-11.279742,"median":-7.770979,"eighty":1275.015426,"marketCap":1366203413.46},{"date":"2024-11-29","current":-475.483527,"twenty":-11.472459,"median":-8.119915,"eighty":1262.088941,"marketCap":1426450581.27},{"date":"2024-12-06","current":-462.637374,"twenty":-11.520238,"median":-8.577538,"eighty":649.987226,"marketCap":1387912124.34},{"date":"2024-12-13","current":-484.970807,"twenty":-11.624468,"median":-8.706737,"eighty":497.452148,"marketCap":1454912419.5},{"date":"2024-12-20","current":-483.00699,"twenty":-11.880785,"median":-8.81707,"eighty":496.483725,"marketCap":1449020970.4},{"date":"2024-12-27","current":-524.024438,"twenty":-12.457859,"median":-8.855646,"eighty":495.297532,"marketCap":1572073311.64},{"date":"2025-01-03","current":-526.020236,"twenty":-230.749328,"median":-8.892068,"eighty":493.586593,"marketCap":1578060706.99},{"date":"2025-01-10","current":-497.27008,"twenty":-384.916258,"median":-8.907363,"eighty":491.400602,"marketCap":1491810238.16},{"date":"2025-01-17","current":-486.412641,"twenty":-393.098632,"median":-8.915467,"eighty":488.91137,"marketCap":1459237922.85},{"date":"2025-01-24","current":-489.294402,"twenty":-425.635451,"median":-8.960053,"eighty":488.290719,"marketCap":1467883205.21},{"date":"2025-01-31","current":-495.059612,"twenty":-434.650258,"median":-9.004691,"eighty":488.174377,"marketCap":1485178837.55},{"date":"2025-02-07","current":-398.440394,"twenty":-438.198605,"median":-9.035763,"eighty":488.116405,"marketCap":1195321181.39},{"date":"2025-02-14","current":-410.047551,"twenty":-437.752568,"median":-9.061129,"eighty":487.121427,"marketCap":1230142653.13},{"date":"2025-02-21","current":-22.522233,"twenty":-439.344773,"median":-9.095438,"eighty":485.768312,"marketCap":1081067217.57},{"date":"2025-02-28","current":-22.859537,"twenty":-437.841775,"median":-9.294936,"eighty":485.214989,"marketCap":1097257759.94},{"date":"2025-03-07","current":-24.283428,"twenty":-437.023459,"median":-9.444366,"eighty":484.854198,"marketCap":1165604557.36},{"date":"2025-03-14","current":605.149026,"twenty":-435.088443,"median":-9.294936,"eighty":488.127999,"marketCap":1210298050.41},{"date":"2025-03-21","current":-25.271265,"twenty":-433.037368,"median":-9.386243,"eighty":488.197645,"marketCap":1213020698.87},{"date":"2025-03-28","current":-24.738754,"twenty":-430.777799,"median":-9.448382,"eighty":488.127999,"marketCap":1187460219.29},{"date":"2025-04-04","current":-24.352592,"twenty":-427.288281,"median":-9.739044,"eighty":487.320423,"marketCap":1168924445.9},{"date":"2025-04-11","current":-23.146184,"twenty":-425.814745,"median":-9.877834,"eighty":485.768312,"marketCap":1111016863.05},{"date":"2025-04-17","current":-23.722243,"twenty":-421.727469,"median":-9.929623,"eighty":485.26875,"marketCap":1138667669.28},{"date":"2025-04-25","current":-21.827382,"twenty":-418.181119,"median":-9.984433,"eighty":484.930955,"marketCap":1353297690.88},{"date":"2025-05-02","current":-23.745782,"twenty":-414.153201,"median":-10.038354,"eighty":483.882407,"marketCap":1472238458.47},{"date":"2025-05-09","current":-22.159707,"twenty":-410.782993,"median":-10.098427,"eighty":483.219619,"marketCap":1373901817.96},{"date":"2025-05-16","current":-22.569779,"twenty":-408.327019,"median":-10.185005,"eighty":482.998999,"marketCap":1399326293.84},{"date":"2025-05-23","current":-22.3193,"twenty":-401.936236,"median":-10.311545,"eighty":482.806461,"marketCap":1383796581.45},{"date":"2025-05-30","current":-25.63971,"twenty":-396.501678,"median":-10.3517,"eighty":480.981026,"marketCap":1589662006.96},{"date":"2025-06-06","current":-27.767026,"twenty":-393.177531,"median":-11.138759,"eighty":477.603988,"marketCap":1721555638.78},{"date":"2025-06-13","current":-28.024212,"twenty":-392.348167,"median":-11.279742,"eighty":476.07077,"marketCap":1737501138.51},{"date":"2025-06-20","current":-28.284472,"twenty":-391.855975,"median":-11.446173,"eighty":475.180835,"marketCap":1753637267.93},{"date":"2025-06-27","current":-27.245913,"twenty":-390.345823,"median":-11.490318,"eighty":474.303192,"marketCap":1689246563.77},{"date":"2025-07-03","current":-31.054113,"twenty":-387.254131,"median":-11.508717,"eighty":473.928378,"marketCap":1925355009.01},{"date":"2025-07-11","current":-31.171056,"twenty":-387.002934,"median":-11.55631,"eighty":465.20437,"marketCap":1932605447.05},{"date":"2025-07-18","current":-32.333828,"twenty":-385.010735,"median":-11.628362,"eighty":463.001654,"marketCap":2004697356.56},{"date":"2025-07-25","current":-33.722781,"twenty":-384.538351,"median":-11.705533,"eighty":457.733314,"marketCap":2090812381.22},{"date":"2025-08-01","current":47.55378,"twenty":-383.933492,"median":-11.954476,"eighty":457.459813,"marketCap":2520350364},{"date":"2025-08-08","current":51.908953,"twenty":-383.123313,"median":-11.661073,"eighty":455.983781,"marketCap":2751174531},{"date":"2025-08-15","current":54.545599,"twenty":-376.128091,"median":-11.608831,"eighty":455.390371,"marketCap":2890916729},{"date":"2025-08-22","current":56.617249,"twenty":-35.016046,"median":-11.531835,"eighty":455.124507,"marketCap":3000714171},{"date":"2025-08-29","current":56.217043,"twenty":-34.774556,"median":-11.495509,"eighty":452.199783,"marketCap":2979503301},{"date":"2025-09-05","current":58.218069,"twenty":-34.549166,"median":-11.478929,"eighty":451.73199,"marketCap":3085557648},{"date":"2025-09-12","current":56.217043,"twenty":-34.412321,"median":-11.359567,"eighty":448.786711,"marketCap":2979503301},{"date":"2025-09-19","current":53.886437,"twenty":-33.856664,"median":-11.154173,"eighty":447.963884,"marketCap":2855981179},{"date":"2025-09-26","current":53.698106,"twenty":-33.722781,"median":-10.357169,"eighty":447.295534,"marketCap":2845999594},{"date":"2025-10-03","current":54.757472,"twenty":-33.367838,"median":-10.329434,"eighty":441.423222,"marketCap":2902146013},{"date":"2025-10-10","current":56.852663,"twenty":-32.522883,"median":-10.193594,"eighty":438.319895,"marketCap":3013191153},{"date":"2025-10-17","current":58.123903,"twenty":-32.191426,"median":-10.136885,"eighty":437.230259,"marketCap":3080566855},{"date":"2025-10-24","current":59.51285,"twenty":-31.936305,"median":-10.050254,"eighty":437.029825,"marketCap":3154181049},{"date":"2025-10-31","current":49.115471,"twenty":-31.768326,"median":-9.994441,"eighty":436.655789,"marketCap":3634544856},{"date":"2025-11-07","current":53.771536,"twenty":-31.614854,"median":-9.940515,"eighty":432.826301,"marketCap":3979093697},{"date":"2025-11-14","current":50.329618,"twenty":-31.467797,"median":-9.877834,"eighty":422.57095,"marketCap":3724391747},{"date":"2025-11-21","current":53.602815,"twenty":-31.224616,"median":-9.739044,"eighty":418.358561,"marketCap":3966608307},{"date":"2025-11-28","current":33.831379,"twenty":-31.10089,"median":-9.452398,"eighty":417.079998,"marketCap":4195090939},{"date":"2025-12-05","current":34.838265,"twenty":-31.035365,"median":-9.406482,"eighty":410.227055,"marketCap":4319944836},{"date":"2025-12-12","current":36.036459,"twenty":-30.949051,"median":-9.187795,"eighty":401.908655,"marketCap":4468520973},{"date":"2025-12-19","current":35.784738,"twenty":-30.882422,"median":-9.077235,"eighty":398.328327,"marketCap":4437307499},{"date":"2025-12-26","current":36.409007,"twenty":-30.838389,"median":-9.037302,"eighty":355.290696,"marketCap":4514716915},{"date":"2026-01-02","current":36.127079,"twenty":-30.768476,"median":-9.020236,"eighty":289.603812,"marketCap":4479757824},{"date":"2026-01-09","current":35.754531,"twenty":-30.593054,"median":-8.994538,"eighty":279.199129,"marketCap":4433561882},{"date":"2026-01-16","current":33.111455,"twenty":-30.162922,"median":-8.926675,"eighty":268.955119,"marketCap":4105820402},{"date":"2026-01-23","current":33.770965,"twenty":-29.887031,"median":-8.908086,"eighty":268.277658,"marketCap":4187599705},{"date":"2026-01-30","current":34.949022,"twenty":-29.648103,"median":-8.907363,"eighty":262.669758,"marketCap":4333678764},{"date":"2026-02-06","current":34.687232,"twenty":-28.870039,"median":-8.882251,"eighty":139.280173,"marketCap":4301216751},{"date":"2026-02-13","current":33.99248,"twenty":-28.353691,"median":-8.848243,"eighty":59.385726,"marketCap":4215067562},{"date":"2026-02-20","current":34.677163,"twenty":-28.238411,"median":-8.731325,"eighty":59.244477,"marketCap":4299968212},{"date":"2026-02-27","current":20.042023,"twenty":-28.144728,"median":-8.655829,"eighty":59.018479,"marketCap":4208824867},{"date":"2026-03-06","current":19.087338,"twenty":-28.07439,"median":-8.478095,"eighty":58.74069,"marketCap":4008341006},{"date":"2026-03-13","current":18.378635,"twenty":-27.9958,"median":-7.827701,"eighty":58.632399,"marketCap":3859513368},{"date":"2026-03-20","current":18.164238,"twenty":-27.926913,"median":-7.703119,"eighty":58.505275,"marketCap":3814489881},{"date":"2026-03-27","current":17.836686,"twenty":-27.874039,"median":-7.514349,"eighty":58.29811,"marketCap":3745703997},{"date":"2026-04-02","current":17.794815,"twenty":-27.836472,"median":-6.995266,"eighty":58.236902,"marketCap":3736911077},{"date":"2026-04-10","current":18.758579,"twenty":-27.751968,"median":-6.894174,"eighty":58.199236,"marketCap":3939301693},{"date":"2026-04-17","current":18.294115,"twenty":-27.679313,"median":16.982644,"eighty":58.114486,"marketCap":3841764047},{"date":"2026-04-24","current":19.252074,"twenty":-27.620734,"median":17.503178,"eighty":58.072112,"marketCap":4042935443},{"date":"2026-05-01","current":17.794815,"twenty":-27.559726,"median":17.69031,"eighty":58.025029,"marketCap":4484293293},{"date":"2026-05-08","current":19.159181,"twenty":-27.4491,"median":17.730951,"eighty":57.88378,"marketCap":4828113496},{"date":"2026-05-15","current":18.302823,"twenty":-27.391357,"median":17.815751,"eighty":57.742531,"marketCap":4612311454},{"date":"2026-05-22","current":18.123811,"twenty":-27.288803,"median":17.836686,"eighty":57.620115,"marketCap":4567200292},{"date":"2026-05-29","current":17.712566,"twenty":-27.245913,"median":17.896416,"eighty":57.582449,"marketCap":4463566543},{"date":"2026-06-05","current":18.118973,"twenty":-27.042075,"median":17.815751,"eighty":57.417659,"marketCap":4565981072},{"date":"2026-06-12","current":18.447969,"twenty":-26.689807,"median":17.954474,"eighty":57.347034,"marketCap":4648888071},{"date":"2026-06-18","current":18.351205,"twenty":-26.089973,"median":18.089943,"eighty":57.271701,"marketCap":4624503659},{"date":"2026-06-26","current":19.976832,"twenty":-25.921332,"median":18.140745,"eighty":57.196369,"marketCap":5034161774},{"date":"2026-07-02","current":19.473662,"twenty":-25.822694,"median":18.173171,"eighty":57.168119,"marketCap":4907362834},{"date":"2026-07-10","current":19.981671,"twenty":-25.687845,"median":18.198802,"eighty":56.975079,"marketCap":5035380995},{"date":"2026-07-17","current":19.63816,"twenty":-25.580272,"median":18.293631,"eighty":56.852663,"marketCap":4948816334},{"date":"2026-07-24","current":19.599455,"twenty":-25.493702,"median":18.346367,"eighty":56.796163,"marketCap":4939062569},{"date":"2026-07-31","current":19.459148,"twenty":-25.451449,"median":18.378635,"eighty":56.749081,"marketCap":4903705172},{"date":"2026-08-07","current":12.819067,"twenty":-25.369514,"median":18.324595,"eighty":56.725539,"marketCap":4563587806},{"date":"2026-08-14","current":12.669892,"twenty":-25.215019,"median":18.293147,"eighty":56.692581,"marketCap":4510481664},{"date":"2026-08-21","current":12.524033,"twenty":-25.098157,"median":18.192754,"eighty":56.645498,"marketCap":4458555659},{"date":"2026-08-28","current":11.701915,"twenty":-25.029903,"median":18.164238,"eighty":56.579583,"marketCap":4165881809},{"date":"2026-09-04","current":11.546111,"twenty":-24.99181,"median":18.121392,"eighty":56.438333,"marketCap":4110415394},{"date":"2026-09-11","current":11.440031,"twenty":-24.975865,"median":18.055625,"eighty":56.292376,"marketCap":4072651026},{"date":"2026-09-16","current":11.343896,"twenty":-24.967722,"median":17.954474,"eighty":56.235876,"marketCap":4038427068}],"updateTime":1789713381460},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INDV\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642447614","title":"Indivior CFO Ryan Preblick sells 36,000 shares for $1.36 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447614","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642447614?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:05","pubTimestamp":1781085927,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals CFO Ryan Preblick sold 36,000 common shares on June 8 at USD 37.7 each.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDLGF9LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Indivior CFO Ryan Preblick sells 36,000 shares for $1.36 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641161357","title":"Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161357","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641161357?lang=en_us&edition=fundamental","pubTime":"2026-06-05 01:30","pubTimestamp":1780594209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Elevance Health (ELV) and Indivior (INDV) with bulli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-elevance-health-elv-indivior-indv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-elevance-health-elv-indivior-indv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","BK4007","LU0061474960.USD","LU0225283273.USD","LU1670628061.USD","LU0187121727.USD","LU1548497426.USD","LU0234570918.USD","LU0742534661.SGD","LU2357305700.SGD","LU2362541273.HKD","BK4585","BK4154","LU2362540622.SGD","SG9999001077.SGD","LU0006306889.USD","LU0211331839.USD","LU1057294990.SGD","LU0208291251.USD","LU2505996509.AUD","LU2430703095.HKD","LU0068578508.USD","LU0114720955.EUR","LU0314106906.USD","LU1489326972.SGD","LU0130102774.USD","ELV","LU0648001328.SGD","LU0433182093.SGD","LU2237957902.USD","LU0878866978.SGD","LU0957791311.USD","LU1280957306.USD","LU0640476718.USD","LU0314104364.USD","LU2592432038.USD","LU0070302665.USD","LU1720051108.HKD","LU1506573853.SGD","SG9999011175.SGD","LU0266013472.USD","LU0130517989.USD","LU0289739699.SGD","SGXZ23171101.USD","LU1670627923.USD","LU0058720904.USD","SG9999004303.SGD","LU1720051017.SGD","LU0106261372.USD","LU0980610538.SGD","LU0122379950.USD","BK4588","LU0170899867.USD","LU2237957811.SGD","LU2430703178.SGD","LU2430703251.USD","LU2362541513.USD","INDV","LU0345770993.USD","LU0477156953.USD","LU0345770308.USD","SG9999003800.SGD","LU2108987350.USD","LU0557290698.USD","LU2505996681.GBP","LU0251142724.SGD","LU0882574055.USD","LU0048573561.USD","LU0251131958.USD","LU0320765489.SGD","LU1815333072.USD","LU1983299246.USD","LU0985489474.SGD","LU1201861249.SGD","LU2244417387.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637449322","title":"Will Real-World SUBLOCADE Adherence Data Reshape Indivior Pharmaceuticals' (INDV) Long-Acting OUD Treatment Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2637449322","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637449322?lang=en_us&edition=fundamental","pubTime":"2026-05-23 19:40","pubTimestamp":1779536446,"startTime":"0","endTime":"0","summary":"In May 2026, Indivior Pharmaceuticals reported two real-world evidence studies showing that adherence to its monthly injectable buprenorphine, SUBLOCADE, was associated with substantially lower relapse risk, fewer serious infections, and reduced healthcare utilization in people with opioid use disorder.\nBecause these analyses linked SUBLOCADE use to both clinical and healthcare resource benefits, they may strengthen the drug’s appeal to clinicians, payers, and treatment programs seeking more...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/will-real-world-sublocade-adherence-data-reshape-indivior-ph","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/will-real-world-sublocade-adherence-data-reshape-indivior-ph","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637950319","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637950319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637950319?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:40","pubTimestamp":1779450047,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-abcellera-biologics-abcl-and-indivior-indv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-abcellera-biologics-abcl-and-indivior-indv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007","BK4196","BK4121","BK4535","HMYY","HIMY","HIYY","ABCL","HIMZ","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636032847","title":"Indivior study links monthly injectable buprenorphine adherence to lower opioid relapse risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2636032847","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636032847?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:04","pubTimestamp":1779282282,"startTime":"0","endTime":"0","summary":"Indivior disclosed results from two retrospective real-world studies that have already been published, linking adherence to its monthly injectable buprenorphine  to improved outcomes in opioid use disorder.In a claims-based analysis, patients who stayed on the monthly injection showed a lower likelihood of returning to opioid use than patients on other medication-assisted treatment approaches.A separate cohort study found patients on the monthly injection had fewer serious infection complications than those treated with daily oral buprenorphine.The same analysis also associated the monthly injection with reduced use of inpatient care, emergency departments, and outpatient services, pointing to potential payer and provider cost implications.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL2SqKMJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","IE00BGHQF748.EUR","NDAQ","BK4585","IE00B3QW5Z07.USD","BK4112","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","LU2210150020.SGD","BK4007","IE00BN0W2V16.EUR","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014039.USD","LU0314104364.USD","IE00BN0W2T93.GBP","SG9999014021.USD","BK4588","LU2210149790.SGD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636153538","title":"Indivior’s Earnings Call Highlights SUBLOCADE-Driven Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2636153538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636153538?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:17","pubTimestamp":1779257864,"startTime":"0","endTime":"0","summary":"Indivior PLC (($INDV)) has held its Q1 earnings call. Read on for the main highlights of the call. Indivior PLC struck an upbeat tone on its latest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indiviors-earnings-call-highlights-sublocade-driven-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indiviors-earnings-call-highlights-sublocade-driven-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636557568","title":"Lifeward names Keith D. Rose chief medical officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2636557568","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636557568?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:06","pubTimestamp":1779192419,"startTime":"0","endTime":"0","summary":"Rose previously served as vice president, medical affairs and medical director, neurosciences at the company.His prior senior roles included medical affairs and clinical leadership positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL318mJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","SG9999014013.SGD","LU2210150020.SGD","BK4548","LU2095319765.USD","LU0154245756.USD","SG9999014005.SGD","BK4112","BK4082","NDAQ","NVCR","SG9999014039.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4533","SG9999014021.USD","LU0823416689.USD","JAZZ","BK4532","LU0889565916.HKD","BK4588","IE00BN0W2V16.EUR","BK4534","LU0320765992.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","INDV","LU0154245673.USD","LU0314104364.USD","BK4585","IE00BN0W2W23.USD","BK4604","LFWD","BK4007","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635851053","title":"Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2635851053","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635851053?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:20","pubTimestamp":1778880007,"startTime":"0","endTime":"0","summary":"Indivior ( ($INDV) ) has provided an announcement. Indivior Pharmaceuticals, Inc. will eliminate the role of Chief Scientific Officer effective Jun...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-eliminates-chief-scientific-officer-role-realigns-leadership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-eliminates-chief-scientific-officer-role-realigns-leadership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037596","title":"Indivior eliminates chief scientific officer role; Heidbreder departs end-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037596","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037596?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:04","pubTimestamp":1778875472,"startTime":"0","endTime":"0","summary":"Indivior will eliminate Chief Scientific Officer role effective June 1, 2026.Christian Heidbreder will continue reporting to CEO in advisory role on special projects through end of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL4FlQyp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037557","title":"Indivior Pharmaceuticals Inc - to Eliminate Chief Scientific Officer Position Effective June 1, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037557","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037557?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:04","pubTimestamp":1778875448,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S14V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633901252","title":"Indivior Pharmaceuticals, Inc : Stifel Raises Target Price to $52 From $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2633901252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633901252?lang=en_us&edition=fundamental","pubTime":"2026-05-06 15:16","pubTimestamp":1778051794,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633911857","title":"A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News","url":"https://stock-news.laohu8.com/highlight/detail?id=2633911857","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633911857?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:23","pubTimestamp":1777976589,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals (INDV) is back on investors' radars after a busy stretch that combined strong Q1 2026 results, a raised full year revenue outlook, and a fresh accelerated share repurchase plan.\nSee our latest analysis for Indivior Pharmaceuticals.\nThe recent Q1 beat, raised 2026 guidance, and the new accelerated share repurchase agreement have all coincided with strong momentum, with a 27.93% 1 month share price return and a very large 1 year total shareholder return that far...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/a-look-at-indivior-pharmaceuticals-nasdaqgsindv-valuation-af-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/a-look-at-indivior-pharmaceuticals-nasdaqgsindv-valuation-af-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955396","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955396","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955396?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:58","pubTimestamp":1777899531,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down 0.5%.Indivior Pharmaceuticals  shares were up more than 3% after the company said it has entered into a $175 million accelerated share repurchase agreement with Barclays Bank, to be executed under the company's existing $400 million buyback program.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4585","BK4588","IBB","LABU","XLV","BK4007","XBI","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930082","title":"Indivior Pharmaceuticals Enters $175 Million Accelerated Share Repurchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930082","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930082?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:42","pubTimestamp":1777894963,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals  has entered into a $175 million accelerated share repurchase agreement with Barclays Bank, to be executed under the company's existing $400 million buyback program, Indivior said Monday.The company will make a $175 million upfront payment to Barclays and expects to receive an initial delivery of 3,717,473 shares following execution.Indivior said it expects final settlement no later than the end of June.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632303619","title":"Indivior announces $175M accelerated share repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2632303619","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632303619?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:17","pubTimestamp":1777893452,"startTime":"0","endTime":"0","summary":"Indivior (INDV) announced that it has entered into a $175M accelerated share repurchase agreement with Barclays. The ASR will be executed under Ind...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/indivior-announces-175m-accelerated-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/indivior-announces-175m-accelerated-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632793756","title":"Indivior Announces $175 Million Accelerated Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2632793756","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632793756?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA35HS5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632626194","title":"Indivior Earnings Call Highlights SUBLOCADE-Fueled Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2632626194","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632626194?lang=en_us&edition=fundamental","pubTime":"2026-05-02 08:09","pubTimestamp":1777680579,"startTime":"0","endTime":"0","summary":"Indivior plc (($INDV)) has held its Q1 earnings call. Read on for the main highlights of the call. Indivior’s latest earnings call struck an upbeat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-earnings-call-highlights-sublocade-fueled-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-earnings-call-highlights-sublocade-fueled-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631589856","title":"Indivior Pharmaceuticals, Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2631589856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631589856?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:22","pubTimestamp":1777555335,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals, Inc reports results for the quarter ended March 31 - Earnings SummaryIndivior Pharmaceuticals, Inc INDV.OQ reported quarterly adjusted earnings of 96 cents per share for the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL8N41D29Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631365166","title":"Indivior Pharmaceuticals Q1 revenue rises 19%, beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2631365166","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631365166?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:12","pubTimestamp":1777547562,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals Q1 revenue rises 19%, beats estimatesOverviewU.S. opioid treatment maker's Q1 revenue rose 19% yr/yr, beating analyst expectationsRecord adjusted EBITDA for Q1 more than doubl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL1N41D0OJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636546","title":"Indivior Pharmaceuticals Q1 Revenue USD 317 Million Vs. IBES Estimate USD 272.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636546","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636546?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:12","pubTimestamp":1777547560,"startTime":"0","endTime":"0","summary":"Apr 30 (Reuters) - Indivior Pharmaceuticals Q1 net income USD 89 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 30-APR-202610:59:11.847 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nRSD388hYw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":98,"code":"91000000","status":"200"}]}}